DeVore, Adam D <br/><br/>
Patient, Provider, and Practice Characteristics Associated With Sacubitril/Valsartan Use in the United States.  [electronic resource] 

 -  Circulation. Heart failure  09 2018 
 - e005400 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1941-3297 
<br/><br/><label>Standard No.: </label>10.1161/CIRCHEARTFAILURE.118.005400  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Ambulatory Care--trends<br/>Aminobutyrates--adverse effects<br/>Angiotensin II Type 1 Receptor Blockers--adverse effects<br/>Biphenyl Compounds<br/>Clinical Decision-Making<br/>Drug Combinations<br/>Female<br/>Guideline Adherence--trends<br/>Heart Failure--diagnosis<br/>Humans<br/>Male<br/>Middle Aged<br/>Neprilysin--antagonists & inhibitors<br/>Patient Selection<br/>Patients<br/>Practice Guidelines as Topic<br/>Practice Patterns, Physicians'--standards<br/>Protease Inhibitors--adverse effects<br/>Registries<br/>Specialization--trends<br/>Tetrazoles--adverse effects<br/>Time Factors<br/>Treatment Outcome<br/>United States--epidemiology<br/>Valsartan